GSK, Sanofi Launch Final Trials for New Covid-19 Vaccine

Vectura Group agrees to £958 million takeover deal by Carlyle Group

Vectura shares spurt 34% to 4-year high as it agrees on £958m Carlyle takeover

After Innova, Pfizer Chooses Bristol As Location for Its New Vaccine Research Centre

Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC

Vaccination Visibly Helps in Abating Existential Threat to Life

3 Global Pharma Stocks in Focus as UK Enters Talks to Waive Vaccine Patents

Oxford Biomedica Shares Surge as Revenue Expectation from AstraZeneca Doubles

GSK-Sanofi Jab Reports Positive Results in Phase 2 Trials

Four Small-Cap Healthcare Stocks That Have Given Over 50 Per Cent Return in A Year

A Glance at 5 Healthcare Penny Stocks

Vaccine Stocks in News: Pfizer’s Profits Rise, AstraZeneca Faces Opposition to CEO’s Bonus Hike

What are the foundation stones laid by Tristel to resume revenue and profit growth from FY22?

How These 2 Healthcare Stocks Performed Amid Pandemic Challenge

Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer

AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Covid-19 Treatment

EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots

10 Cheap Healthcare Stocks to Ponder Over This Easter

Moderna vaccine to be rolled out in April as UK aims to vaccinate all adults by July

Astrazeneca Vaccine Less Effective Than Earlier Touted, Claims Latest Trial Results